JPMorgan Chase & Co’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $860K | Sell |
|
|||||
|
2025
Q1 | $1.5M | Sell |
|
|||||
|
2024
Q4 | $23.2M | Buy |
|
|||||
|
2024
Q3 | $33.7M | Buy |
|
|||||
|
2024
Q2 | $2.28M | Sell |
|
|||||
|
2024
Q1 | $4.13M | Buy |
|
|||||
|
2023
Q4 | $2.46M | Buy |
|
|||||
|
2023
Q3 | $3.2M | Sell |
|
|||||
|
2023
Q2 | $4.08M | Sell |
|
|||||
|
2023
Q1 | $54.5M | Sell |
|
|||||
|
2022
Q4 | $56M | Buy |
|
|||||
|
2022
Q3 | $91.5M | Buy |
|
|||||
|
2022
Q2 | $100M | Buy |
|
|||||
|
2022
Q1 | $120M | Sell |
|
|||||
|
2021
Q4 | $147M | Sell |
|
|||||
|
2021
Q3 | $195M | Sell |
|
|||||
|
2021
Q2 | $204M | Buy |
|
|||||
|
2021
Q1 | $156M | Buy |
|
|||||
|
2020
Q4 | $116M | Buy |
|